Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dolores Schendel Insider Profile
4 Followers
Dolores Schendel, Chief Scientific Officer at Medigene, holds ― shares in Medigene (Ticker: GB:0QGJ).
Dolores Schendel has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Dolores Schendel does not currently own shares as a corporate insider.
A breakdown of Dolores Schendel's holdings
Insider Roles
Chief Scientific Officer
Roles that Dolores Schendel holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Dolores Schendel
Dolores Schendel's Trading History
List of latest transactions for each holding click on a transaction to see Dolores Schendel's performance on stock
You May Also Like
Dolores Schendel insider profile FAQ
What is the percentage of profitable transactions made by Dolores Schendel?
The percentage of profitable transactions made by Dolores Schendel is ―.
What is the average return per transaction made by Dolores Schendel?
The average return per transaction made by Dolores Schendel is ―.
What stocks does Dolores Schendel hold?
Dolores Schendel holds: GB:0QGJ stocks.
What was Dolores Schendel’s latest transaction?
Dolores Schendel latest transaction was an Uninformative Sell of ―.
What was Dolores Schendel's most profitable transaction?
Dolores Schendel’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Dolores Schendel's role in Medigene?
Dolores Schendel's role in Medigene is Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.